Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.

Identifieur interne : 000337 ( PubMed/Corpus ); précédent : 000336; suivant : 000338

Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.

Auteurs : Herman Schroë ; Andrew H. Holden ; Yann Goueffic ; Shirley J. Jansen ; Patrick Peeters ; Koen Keirse ; Wulf Ito ; Frank Vermassen ; Antonio Micari ; Erwin Blessing ; Michael R. Jaff ; Thomas Zeller

Source :

RBID : pubmed:29086462

Abstract

The purpose of this study was to assess the safety and performance of Stellarex Drug-coated balloon (DCB).

DOI: 10.1002/ccd.27348
PubMed: 29086462

Links to Exploration step

pubmed:29086462

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.</title>
<author>
<name sortKey="Schroe, Herman" sort="Schroe, Herman" uniqKey="Schroe H" first="Herman" last="Schroë">Herman Schroë</name>
<affiliation>
<nlm:affiliation>Ziekenhuis Oost-Limburg, Genk, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Holden, Andrew H" sort="Holden, Andrew H" uniqKey="Holden A" first="Andrew H" last="Holden">Andrew H. Holden</name>
<affiliation>
<nlm:affiliation>Department of Interventional Radiology, Auckland City Hospital, Auckland, New Zealand.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Goueffic, Yann" sort="Goueffic, Yann" uniqKey="Goueffic Y" first="Yann" last="Goueffic">Yann Goueffic</name>
<affiliation>
<nlm:affiliation>CHU de Nantes, Nantes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Jansen, Shirley J" sort="Jansen, Shirley J" uniqKey="Jansen S" first="Shirley J" last="Jansen">Shirley J. Jansen</name>
<affiliation>
<nlm:affiliation>Vascular and Endovascular Surgery, Sir Charles Gairdner Hospital, Health and Medical Sciences, University of Western Australia, School of Population Health, Curtin University, Perth, Western Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Peeters, Patrick" sort="Peeters, Patrick" uniqKey="Peeters P" first="Patrick" last="Peeters">Patrick Peeters</name>
<affiliation>
<nlm:affiliation>Department of Cardiovascular and Thoracic Surgery, Imelda Hospital, Bonheiden, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Keirse, Koen" sort="Keirse, Koen" uniqKey="Keirse K" first="Koen" last="Keirse">Koen Keirse</name>
<affiliation>
<nlm:affiliation>Department of Vascular Surgery, Heilig Hart Hospital, Tienen, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ito, Wulf" sort="Ito, Wulf" uniqKey="Ito W" first="Wulf" last="Ito">Wulf Ito</name>
<affiliation>
<nlm:affiliation>Medical Department II, Experimental Angiology, University Hospital Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Vermassen, Frank" sort="Vermassen, Frank" uniqKey="Vermassen F" first="Frank" last="Vermassen">Frank Vermassen</name>
<affiliation>
<nlm:affiliation>Department of Vascular Surgery, Universitair Ziekenhuis Gent, Ghent, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Micari, Antonio" sort="Micari, Antonio" uniqKey="Micari A" first="Antonio" last="Micari">Antonio Micari</name>
<affiliation>
<nlm:affiliation>GVM Care & Research Interventional Cardiology Unit, Maria Cecilia Hospital, Cotignola, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Blessing, Erwin" sort="Blessing, Erwin" uniqKey="Blessing E" first="Erwin" last="Blessing">Erwin Blessing</name>
<affiliation>
<nlm:affiliation>SRH Klinikum Karlsbad Langensteinbach, Karlsbad, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Jaff, Michael R" sort="Jaff, Michael R" uniqKey="Jaff M" first="Michael R" last="Jaff">Michael R. Jaff</name>
<affiliation>
<nlm:affiliation>VasCore, Massachusetts General Hospital, Boston, MA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zeller, Thomas" sort="Zeller, Thomas" uniqKey="Zeller T" first="Thomas" last="Zeller">Thomas Zeller</name>
<affiliation>
<nlm:affiliation>Angiology Division, University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:29086462</idno>
<idno type="pmid">29086462</idno>
<idno type="doi">10.1002/ccd.27348</idno>
<idno type="wicri:Area/PubMed/Corpus">000337</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000337</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.</title>
<author>
<name sortKey="Schroe, Herman" sort="Schroe, Herman" uniqKey="Schroe H" first="Herman" last="Schroë">Herman Schroë</name>
<affiliation>
<nlm:affiliation>Ziekenhuis Oost-Limburg, Genk, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Holden, Andrew H" sort="Holden, Andrew H" uniqKey="Holden A" first="Andrew H" last="Holden">Andrew H. Holden</name>
<affiliation>
<nlm:affiliation>Department of Interventional Radiology, Auckland City Hospital, Auckland, New Zealand.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Goueffic, Yann" sort="Goueffic, Yann" uniqKey="Goueffic Y" first="Yann" last="Goueffic">Yann Goueffic</name>
<affiliation>
<nlm:affiliation>CHU de Nantes, Nantes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Jansen, Shirley J" sort="Jansen, Shirley J" uniqKey="Jansen S" first="Shirley J" last="Jansen">Shirley J. Jansen</name>
<affiliation>
<nlm:affiliation>Vascular and Endovascular Surgery, Sir Charles Gairdner Hospital, Health and Medical Sciences, University of Western Australia, School of Population Health, Curtin University, Perth, Western Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Peeters, Patrick" sort="Peeters, Patrick" uniqKey="Peeters P" first="Patrick" last="Peeters">Patrick Peeters</name>
<affiliation>
<nlm:affiliation>Department of Cardiovascular and Thoracic Surgery, Imelda Hospital, Bonheiden, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Keirse, Koen" sort="Keirse, Koen" uniqKey="Keirse K" first="Koen" last="Keirse">Koen Keirse</name>
<affiliation>
<nlm:affiliation>Department of Vascular Surgery, Heilig Hart Hospital, Tienen, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ito, Wulf" sort="Ito, Wulf" uniqKey="Ito W" first="Wulf" last="Ito">Wulf Ito</name>
<affiliation>
<nlm:affiliation>Medical Department II, Experimental Angiology, University Hospital Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Vermassen, Frank" sort="Vermassen, Frank" uniqKey="Vermassen F" first="Frank" last="Vermassen">Frank Vermassen</name>
<affiliation>
<nlm:affiliation>Department of Vascular Surgery, Universitair Ziekenhuis Gent, Ghent, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Micari, Antonio" sort="Micari, Antonio" uniqKey="Micari A" first="Antonio" last="Micari">Antonio Micari</name>
<affiliation>
<nlm:affiliation>GVM Care & Research Interventional Cardiology Unit, Maria Cecilia Hospital, Cotignola, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Blessing, Erwin" sort="Blessing, Erwin" uniqKey="Blessing E" first="Erwin" last="Blessing">Erwin Blessing</name>
<affiliation>
<nlm:affiliation>SRH Klinikum Karlsbad Langensteinbach, Karlsbad, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Jaff, Michael R" sort="Jaff, Michael R" uniqKey="Jaff M" first="Michael R" last="Jaff">Michael R. Jaff</name>
<affiliation>
<nlm:affiliation>VasCore, Massachusetts General Hospital, Boston, MA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zeller, Thomas" sort="Zeller, Thomas" uniqKey="Zeller T" first="Thomas" last="Zeller">Thomas Zeller</name>
<affiliation>
<nlm:affiliation>Angiology Division, University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions</title>
<idno type="eISSN">1522-726X</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The purpose of this study was to assess the safety and performance of Stellarex Drug-coated balloon (DCB).</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">29086462</PMID>
<DateCreated>
<Year>2017</Year>
<Month>10</Month>
<Day>31</Day>
</DateCreated>
<DateRevised>
<Year>2017</Year>
<Month>10</Month>
<Day>31</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1522-726X</ISSN>
<JournalIssue CitedMedium="Internet">
<PubDate>
<Year>2017</Year>
<Month>Oct</Month>
<Day>31</Day>
</PubDate>
</JournalIssue>
<Title>Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions</Title>
<ISOAbbreviation>Catheter Cardiovasc Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/ccd.27348</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The purpose of this study was to assess the safety and performance of Stellarex Drug-coated balloon (DCB).</AbstractText>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">DCB coatings differ in excipients, paclitaxel dose, and coating morphologies. Due to these differences, a class effect with DCBs has not been demonstrated. Consequently, each DCB needs to be evaluated independently based on its own clinical study results.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The ILLUMENATE Global Study is a prospective, multicenter, single-arm study. Patients with intermittent claudication or ischemic rest pain due to superficial femoral artery (SFA) and/or popliteal peripheral artery disease (PAD) were treated with the Stellarex DCB. The primary efficacy endpoint was primary patency, defined as freedom from restenosis with peak systolic velocity ratio ≤2.5 or clinically-driven target lesion revascularization (CD-TLR) at 12 months. The primary safety endpoint was freedom from device and procedure-related death through 30 days postprocedure and freedom from target limb major amputation and CD-TLR through 12 months.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 417 lesions were treated in 371 patients. The mean lesion length was 7.5 ± 5.3 cm, 40.8% of lesions were severely calcified per core laboratory fluoroscopy criteria and 31.3% were total occlusions. Primary patency by independent duplex core lab evaluation was 81.4% and the freedom from CD-TLR was 94.8% day 365 per Kaplan-Meier estimate. The majority of patients experienced improvements in their Rutherford classification (90.3%) and walking impairment questionnaire score (83.6%) at 12 months compared to baseline.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study validated previous positive findings and confirms the strong safety profile and effectiveness outcomes.</AbstractText>
<CopyrightInformation>© 2017 The Authors. Catheterization and Cardiovascular Interventions Published by Wiley Periodicals, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Schroë</LastName>
<ForeName>Herman</ForeName>
<Initials>H</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-4568-2458</Identifier>
<AffiliationInfo>
<Affiliation>Ziekenhuis Oost-Limburg, Genk, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Holden</LastName>
<ForeName>Andrew H</ForeName>
<Initials>AH</Initials>
<AffiliationInfo>
<Affiliation>Department of Interventional Radiology, Auckland City Hospital, Auckland, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goueffic</LastName>
<ForeName>Yann</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>CHU de Nantes, Nantes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jansen</LastName>
<ForeName>Shirley J</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo>
<Affiliation>Vascular and Endovascular Surgery, Sir Charles Gairdner Hospital, Health and Medical Sciences, University of Western Australia, School of Population Health, Curtin University, Perth, Western Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peeters</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular and Thoracic Surgery, Imelda Hospital, Bonheiden, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Keirse</LastName>
<ForeName>Koen</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Vascular Surgery, Heilig Hart Hospital, Tienen, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ito</LastName>
<ForeName>Wulf</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Medical Department II, Experimental Angiology, University Hospital Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Cardiology, University Hospital Hamburg Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Max-Planck Institute of Heart and Lung Research, Ludwigstraße 43, 61231, Bad Nauheim, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Cardiovascular Center Oberallgaeu-Kempten, Academic Teaching Hospital, University of Ulm, Im Stillen 2, Immenstadt, 87509, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vermassen</LastName>
<ForeName>Frank</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Vascular Surgery, Universitair Ziekenhuis Gent, Ghent, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Micari</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>GVM Care & Research Interventional Cardiology Unit, Maria Cecilia Hospital, Cotignola, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blessing</LastName>
<ForeName>Erwin</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>SRH Klinikum Karlsbad Langensteinbach, Karlsbad, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jaff</LastName>
<ForeName>Michael R</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>VasCore, Massachusetts General Hospital, Boston, MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zeller</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Angiology Division, University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2017</Year>
<Month>10</Month>
<Day>31</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Catheter Cardiovasc Interv</MedlineTA>
<NlmUniqueID>100884139</NlmUniqueID>
<ISSNLinking>1522-1946</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">drug-coated balloon</Keyword>
<Keyword MajorTopicYN="N">peripheral arterial disease</Keyword>
<Keyword MajorTopicYN="N">superficial femoral artery</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>08</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2017</Year>
<Month>08</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>08</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>11</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>11</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>11</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">29086462</ArticleId>
<ArticleId IdType="doi">10.1002/ccd.27348</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000337 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000337 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:29086462
   |texte=   Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:29086462" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024